CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-10 | Kramer Robin Chief Accounting Officer | Shares withheld for taxes | −67 | $286.30 | $19K | 3,830.75 |
| 2023-02-10 | Kramer Robin Chief Accounting Officer | Shares withheld for taxes | −261 | $286.30 | $75K | 3,569.75 |
| 2023-02-10 | Kramer Robin Chief Accounting Officer | Option exercise · Restricted Stock Unit | −833 | 1,667 | ||
| 2023-02-10 | Kramer Robin Chief Accounting Officer | Option exercise · Restricted Stock Unit | −228 | 278 | ||
| 2023-02-10 | Kramer Robin Chief Accounting Officer | Other disposition · Restricted Stock Unit | −278 | 0 | ||
| 2023-02-10 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise | +3,256 | 10,001 | ||
| 2023-02-10 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Shares withheld for taxes | −1,105 | $286.30 | $316K | 8,896 |
| 2023-02-10 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise · Restricted Stock Unit | −3,256 | 6,514 | ||
| 2023-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +2,271 | 6,379.29 | ||
| 2023-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −685 | $286.30 | $196K | 5,694.29 |
| 2023-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +340 | 6,034.29 | ||
| 2023-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −537 | $286.30 | $154K | 5,497.29 |
| 2023-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −165 | $286.30 | $47K | 5,332.29 |
| 2023-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −2,271 | 4,544 | ||
| 2023-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −340 | 416 | ||
| 2023-02-10 | Murphy Nicole Head of Pharm Ops and Tech | Other disposition · Restricted Stock Unit | −416 | 0 | ||
| 2023-02-10 | Singhal Priya Head of Development | Option exercise | +1,211 | 3,863.39 | ||
| 2023-02-10 | Singhal Priya Head of Development | Shares withheld for taxes | −372 | $286.30 | $107K | 3,491.39 |
| 2023-02-10 | Singhal Priya Head of Development | Option exercise · Restricted Stock Unit | −1,211 | 2,424 | ||
| 2023-02-08 | Murphy Nicole Head of Pharm Ops and Tech | Grant or award · Restricted Stock Unit | +6,305 | 6,305 |
Page 25 of 29 · 579 trades